Personal Genome Diagnostics Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System Under the deal, DUHS will establish PGDx's next-generation sequencing-based Elio Tissue Complete platform for the genomic profiling of cancer in its lab. Personal Genome Diagnostics to Build Commercial Infrastructure, Drive Partnerships With New Funding Premium The firm expects to release an expanded liquid biopsy panel this year to help pharmaceutical partners perform blood-based biomarker discovery work. Qiagen Launches 'Digital Partner' Program to Expand Bioinformatics Reach Initial partners in the program include Thermo Fisher Scientific, GNS Healthcare, DNAnexus, Personal Genome Diagnostics, and the Wellcome Sanger Institute. Personal Genome Diagnostics Raises $103M in Series C Financing The firm will use the proceeds to expand its tissue and liquid biopsy product portfolio, as well as to fund future pharma and biotechnology partnerships. PGDx, Qiagen Partner on Clinical Decision Support for Molecular Cancer Testing Laboratories that purchase PGDx Elio genomic profiling tests will receive access to Qiagen's QCI Interpret One for rapid, evidence-based variant interpretation. Jan 11, 2021 PGDx, Almac Sign Agreement to Improve Pharma Access to Tumor Profiling Assays Sep 22, 2020 Genosity Inks Comarketing Agreement with Personal Genome Diagnostics Apr 27, 2020 FDA Clears Cancer Genomic Profiling Kit From Personal Genome Diagnostics Apr 24, 2020 People in the News: Megan Bailey, Maureen Cronin, Ronald Park, Ingo Chakravarty, More Feb 10, 2020 Through Mayo Clinic Pact, PGDx Hopes to Show Clinical Utility for NGS Tissue, Liquid Biopsy Assays Premium Jan 15, 2020 PGDx, Eisai to Develop Next-Generation Sequencing Biomarker Assay Jan 8, 2020 Personal Genome Diagnostics, Mayo Clinic to Collaborate on Cancer Genomic Tests Jan 6, 2020 Guardant Health CEO Deleted Email Evidence After Lawsuit Deposition Dec 4, 2019 PGDx Gets IDE For Tissue NGS Test in Merck Immunotherapy Trial Sep 25, 2019 Personal Genome Diagnostics Gets CE Mark for Elio Tissue Complete Assay Sep 23, 2019 PGDx Shares New MSI Data, Provides Update on FDA Bid for Pan-Cancer IVDs Premium Jun 26, 2019 Allegations of Joint Defense Agreement, Funneled Documents Arise in Guardant Health Patent Suits May 16, 2019 Personal Genome Diagnostics Alleges Patent Fraud by Guardant Health in Countersuit Mar 14, 2019 PGDx Liquid Biopsy Assay Gets CE Marking Jan 7, 2019 PGDx, PathGroup to Co-Develop Genomic Profiling Assay Jan 3, 2019 PGDx Inks Agreements With KingMed, Merck for Tissue-Based TMB Testing Oct 9, 2018 PGDx Liquid Biopsy Assay to be Used in Cancer Drug Study Oct 4, 2018 Innovatus Pledges $42M to PGDx to Support IVD Development Sep 10, 2018 PGDx Expects New Automated Variant Caller to Support NGS Kit Development Premium Jul 24, 2018 Personal Genome Diagnostics Gets FDA Breakthrough Device Designation for Liquid Biopsy Load More Breaking News Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project BGI Americas Collaborating With Champions Oncology on Proteomic Cancer Research Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.